Serum potassium level on hospital arrival and survival after out-of-hospital cardiac arrest: The CRITICAL study in Osaka, Japan.


Journal

European heart journal. Acute cardiovascular care
ISSN: 2048-8734
Titre abrégé: Eur Heart J Acute Cardiovasc Care
Pays: England
ID NLM: 101591369

Informations de publication

Date de publication:
Nov 2020
Historique:
pubmed: 14 5 2019
medline: 17 6 2021
entrez: 14 5 2019
Statut: ppublish

Résumé

Little is known about the association between serum potassium level on hospital arrival and neurological outcome after out-of-hospital cardiac arrest (OHCA). We investigated whether the serum potassium level on hospital arrival had prognostic indications for patients with OHCA. This prospective, multicenter observational study conducted in Osaka, Japan (CRITICAL study) enrolled consecutive patients with OHCA transported to 14 participating institutions from 2012 to 2016. We included adult patients aged ⩾18 years with OHCA of cardiac origin who achieved return of spontaneous circulation and whose serum potassium level on hospital arrival was available. Based on the serum potassium level, patients were divided into four quartiles: Q1 (K ⩽3.8 mEq/L), Q2 (3.8< K⩽4.5 mEq/L), Q3 (4.5< K⩽5.6 mEq/L) and Q4 (K >5.6 mEq/L). The primary outcome was one-month survival with favorable neurological outcome, defined as cerebral performance category scale 1 or 2. A total of 9822 patients were registered, and 1516 of these were eligible for analyses. The highest proportion of favorable neurological outcome was 44.8% (189/422) in Q1 group, followed by 30.3% (103/340), 11.7% (44/375) and 4.5% (17/379) in the Q2, Q3 and Q4 groups, respectively ( High serum potassium level was significantly and dose-dependently associated with poor neurological outcome. Serum potassium on hospital arrival would be one of the effective prognostic indications for OHCA achieving return of spontaneous circulation.

Sections du résumé

BACKGROUND BACKGROUND
Little is known about the association between serum potassium level on hospital arrival and neurological outcome after out-of-hospital cardiac arrest (OHCA). We investigated whether the serum potassium level on hospital arrival had prognostic indications for patients with OHCA.
METHODS METHODS
This prospective, multicenter observational study conducted in Osaka, Japan (CRITICAL study) enrolled consecutive patients with OHCA transported to 14 participating institutions from 2012 to 2016. We included adult patients aged ⩾18 years with OHCA of cardiac origin who achieved return of spontaneous circulation and whose serum potassium level on hospital arrival was available. Based on the serum potassium level, patients were divided into four quartiles: Q1 (K ⩽3.8 mEq/L), Q2 (3.8< K⩽4.5 mEq/L), Q3 (4.5< K⩽5.6 mEq/L) and Q4 (K >5.6 mEq/L). The primary outcome was one-month survival with favorable neurological outcome, defined as cerebral performance category scale 1 or 2.
RESULTS RESULTS
A total of 9822 patients were registered, and 1516 of these were eligible for analyses. The highest proportion of favorable neurological outcome was 44.8% (189/422) in Q1 group, followed by 30.3% (103/340), 11.7% (44/375) and 4.5% (17/379) in the Q2, Q3 and Q4 groups, respectively (
CONCLUSIONS CONCLUSIONS
High serum potassium level was significantly and dose-dependently associated with poor neurological outcome. Serum potassium on hospital arrival would be one of the effective prognostic indications for OHCA achieving return of spontaneous circulation.

Identifiants

pubmed: 31081678
doi: 10.1177/2048872619848883
doi:

Substances chimiques

Biomarkers 0
Potassium RWP5GA015D

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

S175-S183

Auteurs

Haruka Shida (H)

Department of Preventive Services, Kyoto University School of Public Health, Japan.

Tasuku Matsuyama (T)

Department of Emergency Medicine, Kyoto Prefectural University of Medicine, Japan.

Taku Iwami (T)

Kyoto University Health Services, Japan.

Satoe Okabayashi (S)

Kyoto University Health Services, Japan.

Tomoki Yamada (T)

Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Emergency and Critical Care Medical Center, Osaka Police Hospital, Japan.

Koichi Hayakawa (K)

Department of Emergency and Critical Care Medicine, Kansai Medical University, Takii Hospital, Moriguchi, Japan.

Kazuhisa Yoshiya (K)

Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Taro Irisawa (T)

Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Kazuo Noguchi (K)

Department of Emergency Medicine, Tane General Hospital, Osaka, Japan.

Tetsuro Nishimura (T)

Department of Critical Care Medicine, Osaka City University, Japan.

Toshifumi Uejima (T)

Department of Emergency and Critical Care Medicine, Kinki University School of Medicine, Osaka-Sayama, Japan.

Yoshiki Yagi (Y)

Osaka Mishima Emergency Critical Care Centre, Takatsuki, Japan.

Takeyuki Kiguchi (T)

Kyoto University Health Services, Japan.
Critical Care and Trauma Center, Osaka General Medical Center, Osaka, Japan.

Masafumi Kishimoto (M)

Osaka Prefectural Nakakawachi Medical Center of Acute Medicine, Higashi-Osaka, Japan.

Makoto Matsuura (M)

Senshu Trauma and Critical Care Center, Osaka, Japan.

Yasuyuki Hayashi (Y)

Senri Critical Care Medical Center, Saiseikai Senri Hospital, Suita, Japan.

Taku Sogabe (T)

Traumatology and Critical Care Medical Center, National Hospital Organization Osaka National Hospital, Japan.

Takaya Morooka (T)

Emergency and Critical Care Medical Center, Osaka City General Hospital, Japan.

Junya Sado (J)

Medicine for Sports and Performing Arts, Department of Health and Sport Sciences, Osaka University Graduate School of Medicine, Japan.

Takefumi Kishimori (T)

Department of Preventive Services, Kyoto University School of Public Health, Japan.

Kosuke Kiyohara (K)

Department of Food Science, Otsuma Women's University, Tokyo, Japan.

Takeshi Shimazu (T)

Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Tetsuhisa Kitamura (T)

Division of Environmental Medicine and Population Sciences, Department of Social and Environmental Medicine, Graduate School of Medicine, Osaka University, Japan.

Takashi Kawamura (T)

Kyoto University Health Services, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH